(Washington Composite Electric) US President Biden Bayeng was diagnosed with crown disease again on Saturday (July 30). He had no symptoms this time and felt good, but he had to disrupt his work trip again because he had to be separated again.
The White House doctor Oconnn said in a memo to the White House that the results of the coronary virus antigen detection received by Biden were positive, and the infection was confirmed that the infection was BA.5.
79 -year -old Biden was diagnosed for the first time on July 21, and the infected was also BA.5 strain, and mild symptoms had mild symptoms.After completing the PAXLOVID treatment for five days of coronary oral administration, he was negative for four consecutive days from July 26, and then resumed official activities.
Okonor said that a few patients with crown diseases taking Paxlovid were positive for re -examination, and they were usually rarely or have no symptoms.Biden did not have symptoms and no need to restore treatment, but it must continue to observe and isolate.
After the testing of Fuyang, I posted a video in Twitter and said, "I was positive this morning. I feel good and will beolate office in the next few days."Tellahua passed the weekend and went to Michigan on August 2, but the itinerary has been canceled.
Biden originally planned to go to Michigan to propagate the chip bill just passed by the House of Representatives.Affected by economic problems such as inflation and rising oil prices, his recent polls have declined, which may impact the Democratic Party's victory in the November election.
PaxLovid is a antiviral drug made by Pfizer, which is used to treat patients with older and other high -risk crown diseases.This drug helps to prevent severe illnesses, but some studies have shown that about 5%of them have rebounded.The American Centers for Disease Control and Prevention (CDC) suggested that these Fuyang patients should be isolated for at least five days.
Fuqi, the chief infectious disease expert in the United States, also recovered after taking Paxlovid earlier. Due to the worseening symptoms after recurrence, he received the second round of treatment.At present, Pfizer is working with the US Food and Drug Administration to finalize the research plan for patients with this drug to treat Fuyang patients.
